Skip to main content
Erschienen in: Medical Oncology 2/2010

01.06.2010 | Original Paper

Comparative proteome analysis of human adenocarcinoma

verfasst von: Gaoming Xiao, Qionghui Lu, Cui Li, Wenxiang Wang, Yuejun Chen, Zhiqiang Xiao

Erschienen in: Medical Oncology | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

This study was designed to use comparative proteomics technology to find the differentially expressed proteins between human lung adenocarcinoma and paired normal tumor-adjacent lung tissues. The total proteins of 20 human lung adenocarcinoma tissues and paired normal tumor-adjacent lung tissues were separated by means of immobilized pH gradient-based two-dimensional gel electrophoresis (2-DE) and Coomassie Blue staining. The differentially expressed proteins were analyzed with image analysis software and then identified by matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS) and quadrupole time of flight mass spectrometry (Q-TOF-MS/MS). (1) Well-resolved, highly reproducible 2-DE patterns of human lung adenocarcinoma and paired normal tumor adjacent lung tissues were obtained. (2) PDQUEST 2D image analysis software was used to analysis 20 cases of lung adenocarcinoma and paired normal lung tissues, 1006 ± 54 spots were matched among tumor tissues and normal lung tissues. Twenty-eight differentially expressed spots were screened. (3) Twenty non-redundant differentially expressed proteins were identified by mass spectrometry, thirteen proteins were up-regulated, and seven proteins were down-regulated, some proteins were involved in the regulation of cell signal transduction or metabolized enzyme of cell. (4) To validate the results screened by proteome research, immunohistochemistry was used to validate several lung adenocarcinoma differentially expressed proteins including 14-3-3 sigma, annexin 1, and manganese superoxide dismutase. The results showed that these three proteins were really differentially expressed between lung adenocarcinoma and paired normal lung tissues. These results will provide scientific foundation and new clue for the research of human lung adenocarcinoma.
Literatur
1.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.CrossRefPubMed Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.CrossRefPubMed
5.
Zurück zum Zitat Hara A, Okayasu I. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol. 2004;108:43–8. doi:10.1007/s00401-004-0860-0.CrossRefPubMed Hara A, Okayasu I. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol. 2004;108:43–8. doi:10.​1007/​s00401-004-0860-0.CrossRefPubMed
7.
Zurück zum Zitat Akahira J, Sugihashi Y, Suzuki T, et al. Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation. Clin Cancer Res. 2004;10:2687–93. doi:10.1158/1078-0432.CCR-03-0510.CrossRefPubMed Akahira J, Sugihashi Y, Suzuki T, et al. Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation. Clin Cancer Res. 2004;10:2687–93. doi:10.​1158/​1078-0432.​CCR-03-0510.CrossRefPubMed
8.
Zurück zum Zitat Logsdon CD, Simeone DM, Binkley C, et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res. 2003;63(10):2649–57.PubMed Logsdon CD, Simeone DM, Binkley C, et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res. 2003;63(10):2649–57.PubMed
11.
Zurück zum Zitat Cheng AL, Huang WG, Chen ZC, et al. Identification of novel biomarkers for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. Clin Cancer Res. 2008;14(2):435–45. doi:10.1158/1078-0432.CCR-07-1215.CrossRefPubMed Cheng AL, Huang WG, Chen ZC, et al. Identification of novel biomarkers for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. Clin Cancer Res. 2008;14(2):435–45. doi:10.​1158/​1078-0432.​CCR-07-1215.CrossRefPubMed
14.
Zurück zum Zitat Petrella A, Festa M, Ercolino SF, et al. Annexin-1 downregulation in thyroid cancer correlates to the degree of tumor differentiation. Cancer Biol Ther. 2006;5(6):643–647. Epub 2006 Jun 11. Petrella A, Festa M, Ercolino SF, et al. Annexin-1 downregulation in thyroid cancer correlates to the degree of tumor differentiation. Cancer Biol Ther. 2006;5(6):643–647. Epub 2006 Jun 11.
16.
Zurück zum Zitat Yang F, Xiao ZQ, Zhang XZ, et al. Identification of tumor antigens in human lung squamous carcinoma by serological proteome analysis. J Proteome Res. 2007;6(2):751–8. doi:10.1021/pr0602287.CrossRefPubMed Yang F, Xiao ZQ, Zhang XZ, et al. Identification of tumor antigens in human lung squamous carcinoma by serological proteome analysis. J Proteome Res. 2007;6(2):751–8. doi:10.​1021/​pr0602287.CrossRefPubMed
17.
Zurück zum Zitat Hu H, Luo ML, Du XL, et al. Up-regulated manganese superoxide dismutase expression increases apoptosis resistance in human esophageal squamous cell carcinomas. Chin Med J (Engl). 2007;120(23):2092–8. Hu H, Luo ML, Du XL, et al. Up-regulated manganese superoxide dismutase expression increases apoptosis resistance in human esophageal squamous cell carcinomas. Chin Med J (Engl). 2007;120(23):2092–8.
Metadaten
Titel
Comparative proteome analysis of human adenocarcinoma
verfasst von
Gaoming Xiao
Qionghui Lu
Cui Li
Wenxiang Wang
Yuejun Chen
Zhiqiang Xiao
Publikationsdatum
01.06.2010
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 2/2010
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-009-9216-x

Weitere Artikel der Ausgabe 2/2010

Medical Oncology 2/2010 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.